New York, NY – October 20, 2022 – Carlin Consumer Health (“Carlin”), a preeminent consumer health business established by Hildred Capital Management, LLC, Bourne Partners Strategic Capital and The Emerson Group, today announced that Scott Chapman has been appointed Chief Executive Officer. Mr. Chapman joins Carlin with over 30 years of consumer products experience and a strong track record for successfully renovating existing brands, driving margin expansion and accelerating value creation in the over-the-counter (“OTC”) space.
“We are thrilled to welcome Scott as Carlin’s first CEO,” said Andrew Goldman, Managing Partner of Hildred Capital Management, LLC. “As a seasoned consumer brand executive, Scott will lead Carlin’s acquisition strategy and help to drive growth of its acquired consumer brands. With more than 15 years of experience providing strategic and operational leadership at OTC businesses, we are confident that Scott is the right person to lead the build-out of Carlin’s platform and drive profitability and growth for the firm’s portfolio of brands, including its flagship brand, Zegerid OTC®.”
“I’m excited by the opportunity to lead Carlin and drive the growth of our business,” said Scott Chapman, Chief Executive Officer at Carlin Consumer Health. “Carlin’s operationally focused strategy and collaborative approach to partnering with retailers will enable us to build great brands and enhance consumer health and wellness. I look forward to working alongside the team at Hildred, Bourne and Emerson to capitalize on compelling market opportunities and drive value creation for all of Carlin’s stakeholders.”
Mr. Chapman joins Carlin from Advanced Vision Research (“AVR”), the consumer health division of Akorn Operating Company LLC, where he most recently served as General Manager and Senior Vice President. At AVR, Mr. Chapman tripled sales, revitalized AVR’s consumer brand portfolio and optimized its global supply chain. Prior to AVR, Mr. Chapman was Executive Director at Bausch + Lomb, where he was responsible for the turnaround of Bausch + Lomb’s OTC eye care business. Previously, Mr. Chapman served as Vice President of Global Marketing of AgroFresh Solutions Inc where he built the international marketing organization and drove rapid global expansion of one of their leading products, SmartFresh™.
Mr. Chapman began his career at leading beverage and food manufacturers, including The Coca-Cola Company and Kellogg Company. He earned his B.S. in Business from Ball State University and his MBA from Southern Methodist University’s Cox School of Business.
Launched in 2022 by healthcare private equity firms Hildred Capital Management, LLC and Bourne Partners Strategic Capital, together with The Emerson Group, Carlin is a preeminent consumer health business established to acquire leading over-the-counter (“OTC”) brands. Carlin’s unique positioning enables it to acquire and commercialize well-established brands as well as support its retail partners and their customers. As part of its formation, Carlin acquired Zegerid OTC®, an OTC proton pump inhibitor used for the treatment of frequent heartburn. For more information, please visit www.carlinconsumerhealth.com.
Hildred is a New York-based private equity investment firm that pursues growth equity investments in middle market healthcare companies with leading products, technologies and services. Hildred invests in companies with revenues of up to $100 million and creates value from pursuing organic growth strategies, driving effective resource allocation, implementing operational improvements, generating business development, and supporting best-in-class management teams. Areas with attractive fundamentals where Hildred may invest include the following healthcare subsectors: healthcare services, consumer products, information technology, medical devices, life science tools and diagnostics, healthcare related development and manufacturing, and pharmaceuticals, as well as related businesses that impact these healthcare subsectors. For more information, please visit www.hildredcapital.com.
Headquartered in Charlotte, NC, Bourne Partners is a financial services firm specializing in the pharma, pharma services, OTC, and consumer health sectors. The firm offers investment banking and advisory services, and through Bourne Partners Strategic Capital (“BPSC”) sources and executes direct private equity investment transactions in Bourne’s key focus areas. As owners and operators with over 20 years of experience, BPSC has investment, strategic, and operational experience in companies ranging from $10mm to $3bn in equity value. In some companies, BPSC was the sole equity investor. In larger platforms including Covis Pharma, Millicent Pharma and PAI, BPSC partnered with Cerberus Capital Management, The Carlyle Group and Enhanced Healthcare, respectively. BPSC employees and partners invest a substantial amount of personal capital into each transaction to ensure true alignment of interests between investors, management and other stakeholders. BPSC seeks to add value to its partner companies and fund investments by applying its network of strategic relationships (both private equity and industry relationships), advisory and consulting expertise, and operating experience to generate a positive outcome for management, employees, and investors. For more information, please visit www.bourne-partners.com.
The Emerson Group is a consumer products equity organization singularly focused on brands reaching maximum potential that connect over-the-counter health and beauty brands to loyal shoppers. The Emerson Group specializes in strategic planning, category assessments, due diligence, acquisition, and feasibility studies. The Emerson Group also provides the efficient logistics infrastructure necessary to build brands and offers data and shopper insights for making connections between brands and their target consumers. The Emerson Group leads the industry as a retail partner of choice and provides advanced analytical tools and research for proprietary insights. With over 25 years of experience, The Emerson Group is able to identify opportunities and activate plans that improve sales fundamentals and brand performance. The company was founded in 1995 and is based in Wayne, Pennsylvania. The Emerson Group has long-standing connections to a strong voice with major and regional retailers and is able to provide expertise, competency, and leadership in sales and support to retail partners and clients. They ensure OTC health and beauty brands are given the attention they deserve. For more information, please visit www.emersongroup.com.
For Carlin Consumer Health:
For Hildred Capital Management, LLC:
Hugh Burns/Pamela Greene/Jacqueline Zuhse
For Bourne Partners Strategic Capital:
For Emerson Group: